ARCHIVES

FDA To Tighten Up Regulations On Anticancer Drug Combinations, Stop “Permissiveness”

This article is from The Cancer Letter archive.

Vol. 02 No. 36 | September 3, 1976

Download PDF Visit The Full Archive

Related Articles

Harkin Withdraws Amendment Allow NIH To Bypass INDS

October 9, 1992

Maxine Singer Wins Top SES Award

January 8, 1988

Number of Clinical R01 Applications Doubles; Funding Rate Below 20%; NCI Execs Not Satisfied

July 17, 1992

NCI to Ask Cancer Panel, NCAB, to Help Respond To Request for Review Of National Cancer Program

December 4, 1992

The Cancer Letter Stands By Story

October 30, 1998

Increase Cancer Center Grants More Than R01s, SPOREs, Report Tells NCI

February 28, 2003